TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33959935

Group type: EXPERIMENTAL
Intervention: rhEPO 500 IU/kg every other day for 2 weeks
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo (equivalent volume of saline)
Number of subjects: 316
Study: 33206052

Group type: EXPERIMENTAL
Intervention: Supported Adoption Program (SAP)
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 1195
Study: 36478762

Group type: EXPERIMENTAL
Intervention: Early initiation of direct oral anticoagulants (DOAC) within 48 hours of minor or moderate stroke, or at day 6-7 following major stroke.
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Late initiation of direct oral anticoagulants (DOAC) after day 3-4 following minor stroke, after day 6-7 following moderate stroke and after day 12-14 following major stroke.
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Early initiation of direct oral anticoagulants (DOAC)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Late initiation of direct oral anticoagulants (DOAC)
Number of subjects: 2000
Study: 33411195

Group type: EXPERIMENTAL
Intervention: Ekso GT
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lokomat
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Overground walking
Number of subjects: 15

Group type: COMPARATOR
Intervention: Robotic treadmill walking
Number of subjects: 15
Study: 36364868

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo milk
Number of subjects: 23

Group type: COMPARATOR
Intervention: Bovine colostrum (BC) and Placebo milk
Number of subjects: 23
Study: 34143698

Group type: EXPERIMENTAL
Intervention: Nurse-led self-management support program (6-week duration)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard usual care
Number of subjects: 154
Study: 32810355

Group type: EXPERIMENTAL
Intervention: RAMP group (multi-disciplinary group education, lifestyle modification, HBPM training)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: RAMP group
Number of subjects: 291

Group type: COMPARATOR
Intervention: RAMP individual group (usual care)
Number of subjects: 291

Group type: COMPARATOR
Intervention: RAMP individual group
Number of subjects: 291
Study: 34350549

Group type: EXPERIMENTAL
Intervention: Group B (family mental disorder history)
Number of subjects: 1652

Group type: EXPERIMENTAL
Intervention: Group S (personal problems)
Number of subjects: 1652

Group type: EXPERIMENTAL
Intervention: Group BS (both personal problems and family history)
Number of subjects: 1652
Study: 34023312

Group type: EXPERIMENTAL
Intervention: 1-step diagnostic testing protocol (75 g, 2-hour oral glucose tolerance test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2-step screening protocol (50 g, 1-hour glucose challenge followed by 100 g, 3-hour oral glucose tolerance test)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1-step diagnostic testing protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2-step screening protocol
Number of subjects: 0
Study: 32020414

Group type: EXPERIMENTAL
Intervention: Metformin plus two HIIT sessions (MET+EX)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Placebo plus two HIIT sessions (EX+CON)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 16
Study: 36272969

Group type: EXPERIMENTAL
Intervention: Oral Testosterone Undecanoate (TU) therapy
Number of subjects: 69
Study: 34721385

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) tablets
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) in addition to pharmacotherapy (SLIT+PT)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Pharmacotherapy (PT) alone
Number of subjects: 332
Study: 35213393

Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE) standardized to 150 mg of EGCG b.i.d. for 3 years
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1001
Study: 32014060

Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone (4 doses of 1 mL of 40 mg/mL over 1 week, every 2 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (1 mg/kg/day, maximal dose 60 mg/day for 5 days)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone
Number of subjects: 96
Study: 33739381

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural human immunodeficiency virus prevention intervention
Number of subjects: 234
Study: 35673509

Group type: EXPERIMENTAL
Intervention: Nigella sativa (N.S) oil supplement, 2000 mg/d for 8 weeks
Number of subjects: 39
Study: 32191366

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (10 sessions)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (adequate dose participants)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care (adequate dose participants)
Number of subjects: 44
Study: 34048643

Group type: EXPERIMENTAL
Intervention: Orthodontic removable traction appliance (ORTA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Untreated control group (UCG)
Number of subjects: 40
Study: 32926410

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Standard dressings (Acticoat™ and Mepitel™)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (Standard dressings)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) and Control group
Number of subjects: 114
Study: 33963947

Group type: EXPERIMENTAL
Intervention: Hydroponic maize fodder at 25% (T1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hydroponic maize fodder at 50% (T2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (0% hydroponic maize fodder)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hydroponic maize fodder supplementation
Number of subjects: 24
Study: 32410425

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) used until 9:00 pm on the day after operation in the trial group
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group with IPC used until 8:00 am the next day after operation
Number of subjects: 94
Study: 33305900

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (0.3 mg/kg)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Propofol anesthesia (normal saline)
Number of subjects: 157
Study: 32977684

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention using a raised bed pool for 3 months
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 104
Study: 35502922

Group type: EXPERIMENTAL
Intervention: Fostemsavir plus optimized background therapy (OBT)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Optimized background therapy (OBT)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Fostemsavir plus OBT
Number of subjects: 371
Study: 34172046

Group type: EXPERIMENTAL
Intervention: Severe metabolic acidosis
Number of subjects: 5425

Group type: EXPERIMENTAL
Intervention: Uraemia
Number of subjects: 5425
Study: 36457353

Group type: EXPERIMENTAL
Intervention: HRV biofeedback training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control arm (no biofeedback training)
Number of subjects: 30
Study: 35694933

Group type: EXPERIMENTAL
Intervention: Mevidalen (30 mg)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Mevidalen (10 mg)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Mevidalen (75 mg)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Actigraphy
Number of subjects: 340

Group type: COMPARATOR
Intervention: iPad app tests (DSST and SWM)
Number of subjects: 340
Study: 33674869

Group type: EXPERIMENTAL
Intervention: Targeted azithromycin treatment (thrice over the following year)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Delayed azithromycin treatment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Targeted azithromycin treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mass azithromycin treatment
Number of subjects: 48
Study: 32613910

Group type: EXPERIMENTAL
Intervention: Indicator species analysis (ISA)
Number of subjects: 0
Study: 35452830

Group type: EXPERIMENTAL
Intervention: CRRT with topical citrate + low-dose LMW heparin-calcium anticoagulation
Number of subjects: 120

Group type: COMPARATOR
Intervention: CRRT with low molecular weight (LMW) heparin-calcium anticoagulation
Number of subjects: 120
Study: 33761839

Group type: EXPERIMENTAL
Intervention: Personalized Feedback Intervention (PFI)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control (smoking information control)
Number of subjects: 95
Study: 32867998

Group type: EXPERIMENTAL
Intervention: Sanitization procedures
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Cleaning procedures
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Processing (before sanitization)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Locations (head puller, picker, cropper, scalder)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Sampling time
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Comparison between plants
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Location effect
Number of subjects: 135
Study: 35775311

Group type: EXPERIMENTAL
Intervention: Adjunctive diode laser application (90s, 810nm, 2.5W, 50Hz, 10ms)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-activated adjunctive diode laser
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Adjunctive diode laser application
Number of subjects: 25
Study: 32694373

Group type: EXPERIMENTAL
Intervention: Postgame PCM cooling packs on the shoulder and forearm
Number of subjects: 16

Group type: COMPARATOR
Intervention: No cooling (control)
Number of subjects: 16
Study: 32780139

Group type: EXPERIMENTAL
Intervention: High add power contact lenses (+2.50 D)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Medium add power contact lenses (+1.50 D)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Single-vision contact lenses
Number of subjects: 294
Study: 34923515

Group type: EXPERIMENTAL
Intervention: Increased CST variability
Number of subjects: 1752
Study: 33137378

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO) 15 mg daily for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32736344

Group type: COMPARATOR
Intervention: HIIT + RT
Number of subjects: 76

Group type: COMPARATOR
Intervention: MICT + RT
Number of subjects: 76
Study: 33957651

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg oral, 36 hours before surgery)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Misoprostol (400 micrograms buccal, 3 hours before surgery)
Number of subjects: 110
Study: 32189654

Group type: EXPERIMENTAL
Intervention: Child-to-child and child-to-parent Information, Education and Communication (IEC) strategy
Number of subjects: 2352

Group type: COMPARATOR
Intervention: Control group (no IEC strategy)
Number of subjects: 2352
Study: 35536245

Group type: EXPERIMENTAL
Intervention: Physical activity coaching and an activity monitor
Number of subjects: 160

Group type: COMPARATOR
Intervention: Attention control intervention (modified coaching sessions and an activity monitor)
Number of subjects: 160
Study: 32525882

Group type: EXPERIMENTAL
Intervention: Care bundle interventions including chest X-ray, CURB-65 severity score, lower respiratory tract samples, and antibiotics within 8 hours from admission.
Number of subjects: 0
Study: 36115950

Group type: EXPERIMENTAL
Intervention: 80 mg/d of iron (Stratum 1)
Number of subjects: 503

Group type: COMPARATOR
Intervention: 40 mg/d of iron (Stratum 1)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: 40 mg/d of iron (Stratum 2)
Number of subjects: 503

Group type: COMPARATOR
Intervention: 20 mg/d of iron (Stratum 2)
Number of subjects: 503
Study: 33175577

Group type: EXPERIMENTAL
Intervention: Standardized mixed liquid meal test (SMT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT)
Number of subjects: 28
Study: 34710557

Group type: EXPERIMENTAL
Intervention: Difamilast ointment 1%
Number of subjects: 364

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 364
Study: 34103385

Group type: EXPERIMENTAL
Intervention: ERCC+MI-E
Number of subjects: 26

Group type: COMPARATOR
Intervention: ERCC alone
Number of subjects: 26
Study: 32103920

Group type: EXPERIMENTAL
Intervention: Inertial training (T group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 20
Study: 35853580

Group type: EXPERIMENTAL
Intervention: 24-week community exercise programme (CEP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard clinical care (control)
Number of subjects: 56
Study: 32890575

Group type: EXPERIMENTAL
Intervention: 300 IR sublingual tablet
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1607
Study: 35668500

Group type: EXPERIMENTAL
Intervention: Curcumin-piperine co-supplementation (500 mg curcumin + 5 mg piperine, 2 capsules daily for 14 days)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (2 capsules daily for 14 days)
Number of subjects: 46
Study: 32641332

Group type: EXPERIMENTAL
Intervention: SP-NoVideo
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: HELP-NoVideo
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: SP-Video
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: HELP-Video
Number of subjects: 240
Study: 34996756

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg orally once daily for 30 days
Number of subjects: 605

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 605
Study: 33528113

Group type: EXPERIMENTAL
Intervention: 30 mg dapoxetine
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 60 mg dapoxetine
Number of subjects: 78
Study: 32678954

Group type: EXPERIMENTAL
Intervention: Non-surgical debridement and a desiccant material (H)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Non-surgical debridement and glycine powder (G)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Non-surgical debridement, desiccant material and glycine powder (HG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-surgical debridement alone (C)
Number of subjects: 64
Study: 35268021

Group type: EXPERIMENTAL
Intervention: Alcohol-free beer enriched with isomaltulose and resistant maltodextrin (IMB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alcohol-free beer enriched with resistant maltodextrin (MB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: White bread (WB) with IMB
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: White bread (WB) with resistant maltodextrin (MB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular alcohol-free beer (RB)
Number of subjects: 30
Study: 33533139

Group type: COMPARATOR
Intervention: Cold water group (Cold Pressor Task)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Exercise group (isometric grip exercise)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Control group (no manipulation)
Number of subjects: 75
Study: 32150722

Group type: EXPERIMENTAL
Intervention: Mindfulness-based program (7 sessions based on mindfulness-acceptance-commitment approach)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (7 presentations on sport-injury psychology)
Number of subjects: 168
Study: 36068501

Group type: EXPERIMENTAL
Intervention: Y-shaped rotatable connector (YRC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Y-shaped connector (YC)
Number of subjects: 60
Study: 33413354

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise program, 3 sessions per week for 12 weeks
Number of subjects: 234

Group type: COMPARATOR
Intervention: Walking, 3 sessions per week for 12 weeks
Number of subjects: 234

Group type: COMPARATOR
Intervention: Waiting-list control, no interventions and/or exercise training
Number of subjects: 234
Study: 35191210

Group type: EXPERIMENTAL
Intervention: Isavuconazonium sulfate (200 mg equivalent of isavuconazole) administered orally or intravenously once daily for 16 days with a loading regimen every 8 hours for the first 48 hours
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Isavuconazonium sulfate (100 mg, 200 mg, and 400 mg equivalent of isavuconazole) administered orally or intravenously (single ascending dose)
Number of subjects: 76
Study: 33238198

Group type: EXPERIMENTAL
Intervention: aPDT + oral hygiene behavior (OHB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lingual scraper + oral hygiene behavior (OHB)
Number of subjects: 40
Study: 34061052

Group type: EXPERIMENTAL
Intervention: Multifaceted interventions targeting attitude, knowledge, time, and resource barriers
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline audit
Number of subjects: 20
Study: 35729626

Group type: EXPERIMENTAL
Intervention: Mobile application 'afterAMI'
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 100
Study: 32462539

Group type: EXPERIMENTAL
Intervention: t‐PAPS patients
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: t‐PAPS patients with venous thrombosis
Number of subjects: 101
Study: 35442957

Group type: EXPERIMENTAL
Intervention: wMel intervention arm
Number of subjects: 60084

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 60084

Group type: EXPERIMENTAL
Intervention: wMel-treated arm
Number of subjects: 60084

Group type: COMPARATOR
Intervention: Untreated arm
Number of subjects: 60084
Study: 32242398

Group type: EXPERIMENTAL
Intervention: Qiguiyin (QGY) formula
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 33663731

Group type: EXPERIMENTAL
Intervention: Transfemoral TAVR with the SAPIEN 3 valve
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1000
Study: 33552050

Group type: EXPERIMENTAL
Intervention: Recombinant FVIII products
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma-derived FVIII products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel non-replacement therapies (including emicizumab)
Number of subjects: 0
Study: 36178679

Group type: EXPERIMENTAL
Intervention: Twice-weekly membrane sweeping
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Once-weekly membrane sweeping
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control (no membrane sweeping)
Number of subjects: 186
Study: 33332933

Group type: EXPERIMENTAL
Intervention: Palbociclib plus exemestane with ovarian function suppression
Number of subjects: 178

Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 178
Study: 33118053

Group type: COMPARATOR
Intervention: Pharmacological intervention
Number of subjects: 0
Study: 33739618

Group type: EXPERIMENTAL
Intervention: SLrhEpo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: ALrhEpo
Number of subjects: 39

Group type: COMPARATOR
Intervention: SLPLA
Number of subjects: 39

Group type: COMPARATOR
Intervention: ALPLA
Number of subjects: 39
Study: 33036605

Group type: EXPERIMENTAL
Intervention: Implementation support for family involvement and psychoeducation for 18 months
Number of subjects: 161

Group type: COMPARATOR
Intervention: Implementation support for family involvement and psychoeducation after 18 months
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Implementation of family involvement measures
Number of subjects: 161
Study: 35969536

Group type: EXPERIMENTAL
Intervention: Targeted antenatal family planning information provision
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 246
Study: 34004390

Group type: EXPERIMENTAL
Intervention: Active video games in fully immersive virtual reality (AVR)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sedentary VR (SVR)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (quiet sitting)
Number of subjects: 29
Study: 33512805

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouth rinse
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 20
Study: 32673177

Group type: EXPERIMENTAL
Intervention: Energy drink expectancies (energy enhancement, anxiety/negative physical effects, withdrawal, appetite suppression)
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Energy enhancement
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Anxiety/negative physical effects
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Withdrawal
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Appetite suppression
Number of subjects: 1246
Study: 33775615

Group type: EXPERIMENTAL
Intervention: Myeloablative conditioning (MAC)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Reduced-intensity conditioning (RIC)
Number of subjects: 272
Study: 32407655

Group type: EXPERIMENTAL
Intervention: Blocked stimuli organization
Number of subjects: 60

Group type: COMPARATOR
Intervention: Random stimuli organization
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Auditory-only stimuli
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Audiovisual stimuli
Number of subjects: 60
Study: 36175710

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Laparoscopy (RAL)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Standard Laparoscopy (SL)
Number of subjects: 369
Study: 34039570

Group type: EXPERIMENTAL
Intervention: Patient navigation intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care plus written information
Number of subjects: 60
Study: 32162796

Group type: EXPERIMENTAL
Intervention: Oncologist training in shared decision making (SDM)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Patient communication aid
Number of subjects: 194

Group type: COMPARATOR
Intervention: Combination of oncologist training and patient communication aid
Number of subjects: 194

Group type: COMPARATOR
Intervention: Oncologist training
Number of subjects: 194
Study: 35400040

Group type: EXPERIMENTAL
Intervention: Education group (reading leaflets)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group (no leaflets)
Number of subjects: 296
Study: 33744393

Group type: EXPERIMENTAL
Intervention: Immersive virtual reality training
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 37
Study: 35947709

Group type: EXPERIMENTAL
Intervention: Endoscopic removal of small, asymptomatic kidney stones
Number of subjects: 73

Group type: COMPARATOR
Intervention: Not removing small, asymptomatic kidney stones (control)
Number of subjects: 73